Background: Although atrial fibrillation (AF) ablation is considered a technically
Introduction
Catheter ablation for atrial fibrillation (AF) has emerged as an alternative to antiarrhythmic drug (AAD) therapy after the failure of at least one AAD, or even as the first line of treatment in selected cases 1-3. Although a wide variety of ablation techniques have been used to treat AF, it is generally agreed that the cornerstone of any transcatheter procedure is the electrical isolation of all pulmonary veins (PVs). This is currently most commonly achieved by encircling the PVs with focal radiofrequency (RF) lesions under the guidance of a 3-dimensional electroanatomical mapping or navigation system. This point-by point ablation technique requires extensive operator experience for efficency and safety, and is usually associated with long procedure times. Novel methods aiming at simpler and faster PV isolation (PVI) have therefore been developed in recent years, including cryoballoon (CB) ablation [4] [5] and multipolar RF ablation with the circular PV ablation catheter (PVAC) [6] [7] [8] [9] . These "single-shot" techniques were designed to create a circular ablation lesion around the PVs after the appropriate positioning of the ablation catheter at the ostium or at the antra of each PV. A number of studies have demonstrated comparable levels of success and safety profile, but shorter procedure times with these simplified methods than with the conventional pointby-point ablation 10-13. With the continuous increase in the number of AF ablation world-wide, the procedure is being introduced into new and less experienced centers. Efficacy and periprocedural complications are known to improve with experience in any invasive procedure including AF ablation although the learning curve effect has not been extensively evaluated. Sairaku et al. 14 have reported a significantly higher incidence of procedure-related complications and a lower arrhythmia-free survival at 6 month follow-up with the double Lasso catheter-guided encircling pulmonary vein isolation in the first 52 as compared with the following 156 patients who underwent the ablation. Wojcik et al 15 have demonstrated a learning curve effect with CB ablation as indicated by the decline in procedure and fluoroscopy times. However, 3 improvement in the long-term outcome over time has been attributed to a more careful patient selection and not to operator experience per se.
We have now investigated the time-dependent changes in procedural parameters, complication rates, and in the 1-year clinical outcome during our initial experience with phased RF ablation.
Methods

Study population
The present study included consecutive patients who underwent PVI with phased RF ablation for paroxysmal or persistent AF at our center between November 01, 2009 and April 30, 2012 and who had regular follow-up during the first 12 months post-ablation. Exclusion criteria included previous AF ablation, long-standing persistent AF, hyper-and hypothyroidism, significant valvular heart disease, heart failure of NYHA class III or IV, a left ventricular (LV) ejection fraction ≤ 40%, a left atrial (LA) diameter exceeding 50 mm, a LA thrombus, unstable angina or myocardial infarction within the last 3 months, severe chronic obstructive pulmonary disease, known bleeding disorders, contraindication to oral anticoagulation and pregnancy. All participating patients signed the informed consent form prior to the procedure.
Patient preparation and pre-procedural evaluation
Patients were admitted to the hospital 1 or 2 days prior to the procedure. Those on oral anticoagulation with a vitamin K antagonist (VKA) continued to take the drug and the procedure was performed with an international normalized ratio in the therapeutic range. For all other patients, low molecular weight heparin was started twice daily in a weight-adjusted dose and administered until 12 hours prior to the procedure. All patients scheduled for ablation were examined by transesophageal echocardiography within 24 hours to rule out an intracardiac thrombus. The LA and PV anatomies were assessed by means of multislice cardiac CT imaging before the ablation. The technical specifications of the circular, multipolar Pulmonary Vein Ablation Catheter (PVAC), the GENius RF generator (Medtronic Inc., Minneapolis, MN, USA) and the methodology used in our center have been described in detail 16-17. Briefly, the catheter was Bipolar/unipolar RF delivery was usually started at a ratio of 4:1 for each PV and changed to a bipolar/unipolar proportion of 2:1 for a deeper lesion when a sufficient reduction in local electrogram amplitude could not be achieved after multiple RF deliveries. RF energy was applied for 60 s, usually 3-4 times per PV, until PVI was achieved. The PV conduction was reassessed after each RF application, the electrodes being advanced inside the ostium.
Follow-up
Patients were usually discharged within 2 days after the ablation. Following the procedure a vitamin K antagonist was continued for at least 3 months. Patients taking an AAD before the procedure continued the medication for 3 months post-ablation. It was then discontinued if the patient was free of an AF relapse. VKA was discontinued 3 months after the ablation only in patients with a CHADS-VASC score of 1 or below, while those patients with a higher stroke risk were kept on oral anticoagulation regardless the results of postablation arrhythmia monitoring. Follow-up visits were scheduled at 6 weeks, and 3, 6, 9 and 12 months post-procedure.
The 12-lead ECG was checked at each follow-up. Additionally, 24-h Holter monitoring was performed at least twice, and also transtelephonic monitoring 3 times for 14-21 days, during the first 6 months. Patients were asked to transmit their rhythm at least 2-3 times a day, and always in the event of any palpitation. During non-telemetry periods of follow-up, patients were encouraged to visit the nearest hospital or outpatient facility to document their rhythm on an ECG whenever they felt any abnormality of their heart beat.
Arrhythmia recurrence was defined as any atrial arrhythmia lasting for 30 s or longer. The definition of long-term success was freedom from any atrial arrhythmia without any AAD, after one procedure with a blanking period in the first 3 months.
End points
The acute endpoint of the procedure was the electrical isolation of all PVs, as confirmed by an entrance block.
Long-term efficacy was defined as freedom from any atrial arrhythmia without a Class I or Class III AAD after one procedure at 12 month follow-up with a blanking period in the first 3 months.
Significant periprocedural complications were defined as any injury which resulted in death or had long-term sequel, required an immediate intervention or prolonged hospital stay.
Statistical analysis
The study period was divided into tierces to include the same number of patients who underwent AF ablation within each tierce. Clinical characteristics, procedural and follow-up data for subjects in each tierce were presented using numbers and frequencies (%) for categorical variables and means with standard deviations (SD) for continuous variables.
Statistical calculations were performed with IBM SPSS Statistics 20 Software.
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The distribution was examined with Kolmogorov-Smirnov test. Discrete variables were analyzed using Chi-square test. ANOVA (Analysis of variances) and Kruskal-Wallis were used for comparisons of groups. Cox regression as univariate test was used to estimate the hazard ratio. P value less than 0.05 was considered significant.
Results
A total of 132 patients were enrolled. Preablation clinical characteristics of the first, second and third 44 patients who underwent PVI with phased RF ablation are displayed in Table 1 . Significant differences between the 3 tierces were found in the age and in the LA size Atrial arrhythmia-free survival rates without AAD at 12 months postablation were 68% , 75%, and 70.75% in Tierce 1, Tierce 2 and Tierce 3, respectively (p=0.772). On Cox proportional hazard analysis which included clinical and procedural variables no significant predictor of arrhythmia recurrence was demonstrated ( Table 2) .
Discussion
Main findings
This study assessed the effects of learning curve on procedural parameters and longterm success during phased RF ablation with the PVAC. Fluoroscopy time and the number of RF applications required for successful PVI declined progressively with more experience, and 7 a similar trend was observed for procedure time. Importantly, no learning curve effect was demonstrated in the success and complication rates.
Previous studies on learning curve in AF ablation
Although AF ablation is considered technically more challenging compared with other ablation procedures, very limited data have been published on the significance of operator experience in relation to the safety and efficacy of the procedure. The first study that specifically addressed the importance of the learning curve during AF ablation was published were also used in that study. The ongoing Victory-AF trial is currently enrolling patients with persistent and long-standing persistent AF using PVAC GOLD the new generation of the PVAC catheter 24 .
Potential implications for clinical practice
Available data suggest that the learning curve in PVI and the influence of previous operator experience on relevant procedural and clinical endpoints might be ablation technology-dependent. Ablation with a single-shot device can be performed not only with shorter procedure and fluoroscopy times as compared with focal ablation, but also with more satisfactory clinical outcome by a well trained electrophysiologist who is proficient in transseptal catheterization and left atrial ablation but is in the early phase of his AF ablation practice. Further, any of these simplified approaches might be a reasonable choice for lower volume centers as a regular performance of a higher number of procedures is required not only to develop but also to maintain the adequate technical skills with point-by-point ablation.
Limitations of the study
This study has several limitations. First, this was a single center, observational patient cohort study including a relatively small number of patients thereby limiting the statistical power. There was however no selection bias for the study as consecutive patients undergoing AF ablation with phased RF were enrolled. Second, the main operator in all procedures had gained previous, although limited experience with CB ablation before he started this study, which required somewhat similar skills as ablation with the PVAC, therefore these results may not necessarily apply to what could be achived by someone with absolutely no experience in AF ablation. Third, although high incidence of new silent cerebral ischemia detected by diffusion-weighted magnetic resonance imaging was reported after phased RF ablations 25, 26 , this subclinical complication was not assessed in this study. However, most recent data indicated a very substantial reduction in silent cerebral embolisation thanks to some technical and procedural modifications in phased RF ablation 27,28.
Conclusions
This study investigated the time-dependent changes in procedural parameters, 
